Ascendis Pharma A/S (ASND) Earnings Date & Reports
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more
ASND is expected to report earnings to fall 70.34% to -24 cents per share on November 13
Q3'25
Est.
$-0.24
Q2'25
Beat
by $0.45
Q1'25
Missed
by $0.11
Q4'24
Beat
by $0.34
Q3'24
Missed
by $0.18
The last earnings report on August 07 showed earnings per share of -81 cents, beating the estimate of -126 cents. With 354.30K shares outstanding, the current market capitalization sits at 11.53B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ASND showed earnings on August 07, 2025. You can read more about the earnings report here.